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Central venous oxygen saturation (ScvO2) >70% or
mixed venous oxygen saturation (SvO2) >65% is
recommended for both septic and non-septic patients.
Although it is the task of experts to suggest clear and
simple guidelines, there is a risk of reducing critical care
to these simple recommendations. This article reviews
the basic physiological and pathological features as well
as the metrological issues that provide clear evidence
that SvO2 and ScvO2 are adaptative variables with large
inter-patient variability. This variability is exemplified in a
modeled population of 1,000 standard ICU patients and
in a real population of 100 patients including 15,860
measurements. In these populations, it can be seen
how optimizing one to three of the four S(c)vO2
components homogenized the patients and yields a
clear dependency with the fourth one. This explains the
discordant results observed in large studies where cardiac
output was increased up to predetermined S(c)vO2
thresholds following arterial oxygen hemoglobin
saturation, total body oxygen consumption needs and
hemoglobin optimization. Although a systematic S(c)vO2
goal-oriented protocol can be statistically profitable before
ICU admission, appropriate intensive care mandates
determination of the best compromise between S(c)vO2
and its four components, taking into account the specific
constraints of each individual patient.can be conveniently formulated as:Introduction
A recent review of the literature concluded that ‘central
venous oxygen saturation (ScvO2) is a very important
measurement, which can be easily taken in a critical care
environment by both medical and nursing staff. It pro-
vides an understanding of the patient's oxygen delivery,
oxygen consumption and cardiac output. It has a keyCorrespondence: pierre.squara@orange.fr
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months following its publication. After this tim
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creativecommons.org/publicdomain/zero/1.0/role within early goal-directed therapy and has been
shown to decrease mortality when taken and analyzed
appropriately’ [1]. Indeed, ScvO2 > 70% or mixed venous
oxygen saturation (SvO2) >65% is recommended for
both septic and non-septic patients [2-4].
There is no debate that a major task of experts is to
determine clear and simple rules for the early treatment
of life-threatening disorders. As a consequence of the
worldwide promotion of these recommendations, how-
ever, there is a risk of reducing intensive care to these sim-
ple protocols. The objective of this review is to highlight
the basic physiological and pathological features as well as
the metrological issues that provide clear evidence that, in
reality, and for each specific patient, SvO2 and ScvO2 are
complex dynamic variables that may not always provide
an appropriate cutoff for all clinical settings [5-7]. This
may explain that targeting unique S(c)vO2 thresholds may
balance positive and negative effects and may produce
hazardous results in large studies.
The fundamental equilibrium
The sine qua non condition for adequate energy supply
is that the circulatory system transports to each cell
enough oxygen (O2), nutrients, and chemicals to ensure
their aerobic respiration [8,9]. ‘Adequate’ means that, at
any time, the difference (gap) between the expected
metabolic needs minus the real O2 consumption (VO2)
must not exceed energy storage. This basic equilibrium
VO2 measuredð Þ ¼ VO2needs − VO2gap ð1Þ
For any cell, tissue, and organ, VO2 is the difference be-
tween arterial and venous O2 flows. For the whole body, if
we ignore the O2 dissolved in the plasma water, which
represents only a few percent of the total O2 blood content,
if we consider that arterial and venous blood flows are rep-
resented by the cardiac output (CO), and if we assume thathe licensee has exclusive rights to distribute this article, in any medium, for 12
e, the article is available under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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concentration (Hb), then we can write:
VO2 ¼ COHb 1:34 SaO2−SvO2ð Þ ð2Þ
where VO2 is in ml/minute.m
2, CO is in L/minute.m2,
Hb is in g/L, and arterial oxygen hemoglobin saturation
(SaO2) and SvO2 are the ratios of arterial and venous
oxygenated Hb over the total Hb per blood unit and,
therefore, dimensionless percentages. The constant 1.34
is the carrying capacity of the oxygenated Hb in millili-
ters of O2 per gram. This equation can be reformulated
as a function of each variable, but its reformulation as a
function of SvO2 is one of the most popular because
SvO2 measurements are precise, accurate, time responsive
and quite easy to monitor [10,11]. Figure 1 shows that the
relationships between SvO2 and its components are not
equivalent and not necessarily linear. As a consequence, a
large change in one variable may be compensated by aFigure 1 Relationships between mixed venous oxygen hemoglobin sa
standard ICU population of 1,000 patients (Excel, Microsoft) with normal distri
to 1) and normal distributions of total body oxygen consumption (VO2) need
and hemoglobin concentration (Hb; 100 ± 15 g/L). Only one of the four comp
relationship with mixed venous oxygen saturation (SvO2) (X-variable). When u
indicate the fluctuations of the Y-variable around its mean value (±2 standard
SvO2. We can see that reference ranges (mean ±2SD) of SaO2, VO2 needs, CO
SvO2, respectively. Thus, CO is not necessarily the predominant component osmall change in another - for example, small changes in
low CO that are compensated for by large changes in
SvO2 and large changes in high CO that are compensated
for by small changes in SvO2:
SvO2 ¼ SaO2−VO2= COHb 1:34ð Þ ð3Þ
If we replace the measured value of VO2 by its two
hidden components seen in [1], we find:
SvO2 ¼ SaO2−VO2needs= COHb 1:34ð Þ
þ VO2gap= COHb 1:34ð Þ ð4Þ
The purpose of the circulatory system, eventually
supported by intensive care, is to nullify the VO2 gap; at
equilibrium, therefore, Equation 4 can be written:
eSvO2 ¼ SaO2−VO2 needs= COHb 1:34ð Þ ð5Þturation and its components. To create these curves, we modeled a
bution of arterial oxygen hemoglobin saturation (SaO2; 0.95 ± 0.05 limited
s (140 ± 30 ml/minute.m2), cardiac output (CO; 3.0 ± 0.5 L/minute.m2)
onents was sequentially changed (Y-variables) to look at its specific
nchanged, variables were set to their mean value. The horizontal arrows
deviations). The vertical arrows show the corresponding fluctuations of
, and Hb are compensated for by a 26%, 50%, 47%, and 40% change in
f SvO2 except when low (left, flat part of the relationship).
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equilibrium.
In reality, the ‘two hands of equality’ in Equation 5 fluc-
tuate around the equilibrium. When SvO2 is superior to
the right hand, a VO2 gap is created, and when below, the
gap is restored. If we subtract Equation 5 from Equation 4,
we can see that the difference SvO2 -
eSvO2 (ΔSvO2) is
related to the VO2 gap:
ΔSvO2 ¼ VO2 gap= COHb 1:34ð Þ ð6Þ
Physiological adaptation
Any change in metabolic needs triggers active neuro-
hormonal regulation to enable the actual VO2 to
equalize to the VO2 needs as soon as possible. Under
basal metabolic conditions, VO2 needs depend mostly
on age, gender, height and weight [12-14]. In the resting
state, physiological changes in the basal metabolism are
mostly due to digestion and body temperature. A normal
meal usually increases the metabolic rate by 4 to 10%
and each degree change in temperature over or under
37°C alters VO2 needs by 13% [8]. Consequently, the ex-
pected VO2 of resting patients may be easily computed
or found from normative tables.
This VO2 adaptation to metabolic needs is primarily
achieved by stimulus-induced catecholamine secretion
modulating global CO and its distribution. SaO2 is main-
tained close to 1 by the ventilation drive triggered by
brain receptors. When low, Hb is also improved, albeit
slowly, by iron mobilization, [15] kidney secretion of
erythropoietin, [16] and the release of young red blood
cells [17,18]. In contrast, no regulatory loop has been
observed for maintaining the mixed venous oxygen par-
tial pressure or SvO2 within specific ranges. Therefore,
SvO2 seems to be a variable that passively follows the
regulation of its components. For any change in VO2
needs, the tissue residual partial pressure of O2 repre-
sents the final adjustment between O2 delivery and
uptake and determines the change in SvO2. The propor-
tional contributions of CO and SvO2 to the changes in
VO2 strongly depend on body position, blood volume,
and the protocol for increasing the requirements. In the
following, we will assume that in ICU patients, lying su-
pine, with acceptable blood volume, two-thirds of the
change in VO2 is achieved by a parallel change in CO
and one-third by an anti-parallel change in SvO2
[19-23]. This allows us to derive the expected adaptive
values of SvO2 as a function of age, gender and
temperature (Figure 2). The two-thirds to one-third bal-
ance, observed in cases of physiologic stress, should be
seen as a pivotal value in critical situations. In case of
limited CO for any reasons, necessary compensationwould be reached by a proportional decrease in SvO2
and vice versa.
The adaptive physiological variability of SvO2 that
maintains VO2 equal to needs can also be shown by its
frequency distribution in large populations of steady-
state patients (Figure 3). We can see that the expected
SvO2 is often below 65% in both modeled and real
anesthetized patients. In real, non-anesthetized patients,
other physiological contributors to metabolic needs,
such as digestion, pain, discomfort, stress, inflammation,
increased work of breathing, and so on, additionally in-
crease this heterogeneity.
Pathological changes
When the VO2 gap exceeds the tissue O2 reserve, the
cell moves from aerobic to anaerobic metabolism, lead-
ing to tissue hypoxia and dysoxia [24,25]. This can be
first observed when the right-hand side of Equation 5 is
excessively low (low SaO2, high VO2 needs, low CO or
low Hb), such that SvO2 cannot decrease proportionally
to maintain the equilibrium and a difference occurs
between limited SvO2 and very low
eSvO2.
A second pathological situation is observed in the case
of impaired tissue O2 convection between hemoglobin
and mitochondria, such that the arterial blood flow is
not sufficiently unloaded and SvO2 increases over
eSvO2.
This can be seen when the O2 gradient is low due to a
deficit in utilization (for example, from mitochondrial
blockage, cyanide poisoning, and so on) and/or when O2
tissue diffusion is impaired by an excessive distance or a
reduced surface area (for example, in the presence of
edema, inflammation, microclots, reduced capillary
density, anatomical and/or functional shunts). In septic
shock or in late stage shock caused by any mechanism,
SvO2 cannot decrease sufficiently due to a combination
of these elementary mechanisms [7,26-29].
In both situations, the parallel changes in SvO2, CO
and Hb predicted by Equation 3 may be lost since VO2
is expected to increase as well up to its needed value.
Except in experimental conditions, these two patho-
logical situations are usually combined [30]. We can
reasonably speculate that, depending on the initial
mechanisms of shock, its magnitude, and the adaptive
possibilities of each patient, SvO2 will cover a wide
range of values and will not provide by itself clear indi-
cations for guiding therapy. The same considerations
will also lead to significant discordance between differ-
ent studies according to the heterogeneity of their
populations for each of the elementary mechanisms
described above [31].
Metrological considerations
The reference method for assessing SvO2 requires mixed
venous blood sampling through a pulmonary artery
Figure 2 Mixed venous oxygen hemoglobin saturation adaptation to fluctuations of related variables. Mixed venous oxygen saturation
(SvO2) changes were modeled in 1,000 patients using JMP (SAS Institute, Cary, North Carolina, USA). In both panels, we used a random uniform
distribution of age (range 20 to 90 years) and temperature (range 34 to 41°C) and the normative tables as modeled by the Hemodyn software®
[7,26-29]. This generates a wide range of total body oxygen consumption (VO2) needs (70 to 290 ml/minute.m
2) and their corresponding cardiac
output values (2.28 to 4.22 L/minute.m2) from which individual values of needed SvO2 can be inferred from Equation 2 according to different
values of hemoglobin concentration and arterial oxygen hemoglobin saturation. In the left-hand panel, only old and hyperthermic patients have
an expected physiological SvO2 < 0.65. In the right-hand panel, most patients have an expected SvO2 < 0.65 in response to a combined mild
decrease in SaO2 and hemoglobin concentration. These examples have been created assuming no VO2 gap. In case of hypoxia, SvO2 values
exceed the modeled value, proportionally to the VO2 gap following Equation 6.
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ation using a multi-wavelength spectrophotometer (co-
oximeter) [32]. When the blood sampling procedure is
correct and the sample is immediately analyzed using a
properly calibrated co-oximeter, the SvO2 measurement
is accurate (bias <0.5%), precise (2 standard deviations
(SD)/mean =1.3%) and linear (R2 = 1) [33,34]. Even withFigure 3 Frequency distribution of mixed venous oxygen hemoglobin
population of 1,000 patients (JMP, SAS Institute, Cary, North Carolina, USA)
computing random gender, normal distribution of age (60 ± 12 years), tem
semi-normal distribution of arterial oxygen hemoglobin saturation (1 to 0.0
a real population of post-cardiosurgery unshocked steady state patients (as
oxygen saturation (SvO2) components (15,860 measurements obtained fromsuch good performance indices, however, the least sig-
nificant change in a unique measurement (2√2 × 2SD/
mean) is 3.7%, meaning that a SvO2 value of 65% needs
to change to >68.7% or <61.3% to have a 95% chance of
being real.
Continuous monitoring of SvO2 using a fiber-optic
sensor placed at the tip of a pulmonary catheter hassaturation in two populations of patients. Left: a modeled
as seen in Figure 2 but mimicking a standard ICU population by
perature (37.5 ± 1.2°C), hemoglobin concentration (100 ± 15 g/L) and
5) and assuming no total body oxygen consumption (VO2) gap. Right:
suming no VO2 gap) with a wide range of changes in mixed venous
a previously published study) [64].
Figure 4 Frequency distribution of mixed venous oxygen hemoglobin saturation in two populations of ‘optimized’ patients according
to the protocol of Rivers and colleagues [52]. The left-hand panel represents the population of 1,000 patients as seen in Figure 3 but total
body oxygen consumption needs and cardiac output (CO) were set at 120% and 130% of the expected values at basal metabolism for
modeling septic conditions. Other variables were distributed as reported by Rivers and colleagues: age =67 ± 17.4 years, 50.8% male sex
ratio, temperature =35.9 ± 3.2°C, hemoglobin concentration (Hb) >100 ± 15 g/L and arterial oxygen hemoglobin saturation (SaO2) >0.93.
The right-hand panel represents the same real population of post-cardiosurgery patients as shown in Figure 3 but restricted to CO >1.3
basal values, Hb >100 ± 15 g/L and SaO2 > 0.93 (8,067 measurements). SvO2, mixed venous oxygen saturation.
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and recalibrated using a co-oximeter [35]. The precision
is necessarily lower (2SD/mean >5%) [10,11], but is com-
pensated by a very fast response (almost instantaneous)
[36], allowing averaging of several elementary measure-
ments (N) in a few milliseconds and decreasing the
standard error of the mean (2SD/√N). Averaging 10
elementary measurements when continuously monitor-
ing SvO2 allows the same least significant changes to be
achieved as when analyzing a unique mixed venous
blood sample.
At the turn of the century, it was suggested that
ScvO2 should be used as a surrogate of SvO2, owing to
the fact that it is easier and less invasive to insert a
central line than a pulmonary catheter. ScvO2 is simi-
lar to SvO2 in normal patients, being about 2 to 3%
lower because many of the vascular circuits that drain
into the inferior vena cava may have non-oxidative
phosphorylation (renal, portal, hepatic blood flows)
and therefore extract less O2 [37,38]. However, several
studies have shown that ScvO2 may not predict SvO2
in patients suffering shock, depending on the O2
flows and O2 extractions of the different tissue com-
partments, and where measurements are taken [39-43].
The coefficient of variation (2SD/mean) between
ScvO2 and SvO2 may exceed ±20% [44,45]. Even paired
changes in ScvO2 and SvO2 are not necessarily parallel;
they were only found in 55% of cases in one study [45].
It is only when considering trend lines that changes in
ScvO2 and SvO2 become more consistent [46].
Clinical evidence
Finally, there is a huge body of evidence (often with a
degree of mathematical evidence) that SvO2 values varywidely in ICU patients, either for physiological, patho-
logical or metrological reasons. Therefore, the appropri-
ate SvO2 for achieving an adequate body energy supply
is specific to each individual patient and to its specific
time-evolving situation. There is no basic evidence for
targeting any clear-cut SvO2 value. From the consider-
ations listed above, it seems more appropriate to tune a
multivariate compromise represented by an acceptable
range of the four SvO2 component trend lines with the
objective of fulfilling global and local metabolic needs.
This compromise must be assessed in terms of predicted
benefit and risk of any change.
A variety of clinical evidence has provided us with a
message in accordance with these fundamentals, show-
ing no interest in targeting specific values of SvO2 and/
or ScvO2 in large populations of patients [47-49].
However, other studies have presented indisputable
evidence that targeting a specific value of SvO2/ScvO2
can be of interest for lactate clearance [50], morbidity
[51], and mortality [52]. Accordingly, the Surviving
Sepsis Campaign recommends maximizing mixed or
central venous oxygen saturation [2]. The contradic-
tion is apparent. As previously mentioned and detailed
above, all results can be predicted by the homogeneity/
heterogeneity of the patient population.
In the Rivers and colleagues’ study [52], which is the
main reference for the hemodynamic recommenda-
tions of the Surviving Sepsis Campaign, the population
was homogenized as much as possible before targeting
the ScvO2. The study included early septic shock
before ICU admission, and thus compared patients at the
same phase of pathological evolution. In addition, the
therapeutic protocol, including sedation, mechanical ven-
tilation and fraction of inspired oxygen adjustment,
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of SaO2. Hemoglobin was also increased when necessary
by blood transfusion. Heart rate and central venous pres-
sure were optimized, thus improving CO as much as pos-
sible. Under these conditions, if a low ScvO2 was found
instead of an expected high value, even taking into consid-
eration a possible discordance between ScvO2 and SvO2,
the probability of insufficient CO was high and use of ino-
tropes was consistent with the basic physiology. This is il-
lustrated in Figure 4, where we used the same populations
as shown in Figure 3 but with the distributions of the
SvO2 components mimicking those of the study by Rivers
and colleagues. In these homogenized populations, the
SvO2 distribution is obviously narrower. If Hb, SaO2 and
VO2 are homogenized, ScvO2 and/or SvO2 are necessarily
more influenced by CO.
From the modeled population seen in Figure 4, we can
simulate the increase in CO required to reach a target
SvO2 of >65% (presumably equivalent to ScvO2 > 70%).
Such an increase would be required in 39.5% of the pa-
tients, up to 1.2 L/minute.m−2 (average 0.17 ± 0.16),
which seems to be a reasonable objective.
However, the Surviving Sepsis Campaign recom-
mended a target Hb of 70 to 90 g/L whereas in Rivers
and colleagues’ study the hematocrit was increased up to
30%, which represents an Hb >100 g/L. This has major
consequences for SvO2. If we consider again the popula-
tion modeled in Figure 4, reducing Hb from 100 to 90 g/
L displaces the frequency distribution leftwards and it
would be more difficult to target SvO2 to >65%. The
simulation shows that an increase in CO would be ne-
cessary for 79.5% of the patients, up to 1.7 L/minute.m2,
with an average increase of 0.39 ± 0.24. If targeting Hb
to 70 g/L, an increase in CO would be necessary for
98.7% of the patients, up to 2.7 L/minute.m2 with a
mean increase of 1.30 ± 0.44. All these estimations are
derived with constant VO2 needs, ignoring the caloric
effects of increasing CO [53]. Therefore, targeting the
same SvO2 objective as Rivers and colleagues without
targeting the same Hb has strong consequences for
CO stimulation. Finally, SvO2 must be viewed as a
compromise. Increasing Hb may have favorable [54] or
detrimental effects [55]. Increasing CO may also have
positive [56,57] or negative results [58-61]. The final de-
cision depends, therefore, on the specific conditions and
limitations of each patient. This statement is reinforced
by two recent reports. In the study of Jones and col-
leagues [62] management to increase lactate clearance
was equivalent to targeting specific ScvO2 values in
septic shock. Moreover, the ProCESS trial has shown
that, in academic hospitals, the Rivers and colleagues’
protocol was not superior to usual care despite signifi-
cant increases in blood transfusion, dobutamine and
vasopressor use [63]. The comparable mortality mayonly be explained by an absence of impact on mortality
of these interventions, which seems unlikely, or by the
fact that targeting a unique ScvO2 value in heteroge-
neous patients may balance positive and negative effects.
Whether a unique SvO2 or ScvO2 goal would be benefi-
cial or not depends, therefore, on the quality of care in
the control group and on the inter-individual dispersion
of the difference between the target and the optimal
ScvO2 value allowing VO2 needs to be met. We have
seen that this optimal value may be far from a fixed tar-
get. These results should not discourage us from moni-
toring SvO2 or ScvO2 but encourage us to include these
variables in a multimodal analysis.
Conclusion
Basic physiology tells us that SvO2 is not a regulated
variable but an adaptive variable depending on four
elementary regulated components: VO2 needs, SaO2,
Hb and CO. Consequently, SvO2 is widely fluctuating.
There is no physiological argument for targeting par-
ticular values of SvO2 (or its surrogate ScvO2) by spe-
cific interventions except in homogenized populations,
where optimizing one to three of the four SvO2 com-
ponents may yield a clear dependency with the fourth
one. This explains the apparently contradictory results
observed in large studies where CO was increased up
to specific SvO2 thresholds and confirms the basic
physiology predicting large inter-patient variability. Al-
though a systematic SvO2 goal-oriented protocol can
be statistically profitable before ICU admission, one
would expect from any trained intensivist a more so-
phisticated, multivariate approach and a determination
of the best compromise between SvO2 and its compo-
nents, taking into account the specific constraints of
each individual patient.
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